Come to this information breakfast to learn about Relevant Health, the new accelerator now accepting applications from health tech startups for its Fall 2015 class!
Relevant Health's five-month program involves an intensive product-focused curriculum that gives founders of health tech startups the skills to define, develop, position and launch a viable health tech product. Companies admitted to the accelerator will have access to a cowork facility along with other support that includes up to $50,000 in funding, mentorship, development support from a pool of software engineers, and access to the local health tech ecosystem. The accelerator will be located in the Rockville Innovation Center.
Relevant Health, a newly launched innovative health technology startup accelerator focused on bringing products to market, announced that it is now accepting applications from health tech startups for its Fall 2015 class. Additionally, the accelerator launched its website and the portal to its streamlined application process. U.S. and international startups are encouraged to apply.
Relevant Health’s five-month program involves an intensive product-focused curriculum that gives founders of health tech startups the skills to define, develop, position and launch a viable health tech product. The new accelerator will be based out of a brand-new cowork space in the Rockville Innovation Center, centrally located in the heart of the Montgomery County (Maryland) life sciences corridor. Companies admitted to the accelerator will have access to the cowork facility along with other support that includes up to $50,000 in funding, mentorship, development support from a pool of software engineers, and access to the local health tech ecosystem.
THURSDAY, JUNE 25, 2015 8:30 am - Institute for Bioscience & Biotechnology Research (IBBR)
Manufacturing Science Analytics: Predictors of Biotherapeutic Product Quality
Industrial, federal, and academic researchers will gather to discuss the current trends in process modeling and its relation to the biotherapeutic "fingerprint." On Thursday, June 25, 2015 at 8:30 am join the thought-leaders, policy-makers, and creators of biosimilars as we present current trends, ideas, and predictions.
The Washington DC/Baltimore chapter of Women In Bio invites you to our July 8, 2015, networking happy hour, hosted by our newest sponsor BioHealth Innovation Inc. in Rockville, Maryland. We will be welcomed by Mr. Richard Bendis, Founder, President and CEO of BioHealth Innovation, Inc., followed by an evening of networking. Please come out and meet our new and exciting professionals from the DC/MD/VA area and learn more about the burgeoning biohealthcare industry in Maryland. Numbers are limited – register early!
MedCity ENGAGE is an executive-level event featuring the most innovative thinking from payers, providers, policymakers, health IT and beyond to highlight best-in-class approaches to one of the biggest challenges in healthcare: patient engagement. It will feature speakers discussing the current attempts to innovate in care delivery and reimbursement, along with the innovations that will form the backbone of technological infrastructure.
United Therapeutics Corp., one of the region's largest bioscience firms, is planning a major expansion of its Silver Spring campus with plans to hire about 100 employees in the next three to six years.
The publicly traded firm, with about 200 D.C.-area employees and $340 million in net income in 2014, wants to develop a six-story building at the southwest corner of Spring Street and Colesville Road connecting to its existing corporate presence in the immediate area. The 121,724-square-foot building, to include new office, lab and retail space, would be developed on the site of what is now a Montgomery County-owned, three-story parking garage that is under contract for sale to United Therapeutics (NASDAQ: UTHR).
Bayer HealthCare and Johns Hopkins University entered into a five-year collaboration to develop ophthalmic therapies that target retinal diseases. They will work together on discovery and development of drugs for treatment of eye diseases such as age-related macular degeneration and diabetic macular edema, among others.
BioBuzz is an ongoing monthly networking group of professionals from all sectors of the Biotech/Pharma/Life-sciences industries. Each month we host a FREE event for like-minded people to come together and network, reconnect with past coworkers, build stronger relationships and share stimulating conversations in a welcoming atmosphere.
This month's event is made possible by our sponsor, Breezio (@brzio), who is helping to advance the pace of research and discovery through their Research Collaboration Platform. Join us at the upcoming Bethesda event - June 25th at Barking Dog Bar - to meet them and learn about Team Science.
Pharmaceuticals giant GlaxoSmithKline could reportedly become the latest takeover target in the industry.
According to the Daily Mail, market participants are speculating that the company may face an approach from Switzerland’s Roche or US company Johnson & Johnson at about 1900p per share.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched new Investigator® STR assay kits for analysis of DNA evidence in forensic laboratories in the United States. The new genetic fingerprint kits provide an integrated solution to simultaneously analyze multiple key genomic markers (short tandem repeats or STRs) for DNA matching. They incorporate the Investigator® Quality Sensor to evaluate the quality of DNA in each sample, a novel QIAGEN technology that enables labs to decide quickly which evidence may provide valuable results - solving cases while saving time and money.
The University of Maryland, Baltimore, will build a new interdisciplinary education facility thanks in part to a gift from a Baltimore construction company.
The university announced Wednesday that it’s getting $3 million from the Whiting-Turner Contracting Company. The money will go toward renovating a vacant building on the university campus in downtown Baltimore. When the work is finished, it will be home to the university’s Interprofessional Education Center.
This is the first in a 3-part series about the use of crowdfunding in health and biotech start-ups. We start with the story of a tech start-up which set records for funding through a Kickstarter campaign, triggering interest in crowdfunding by entrepreneurs in capital-intensive industries. Part 2 will discuss the JOBS Act and the government’s attempt to overcome regulatory hurdles facing companies which want to use crowdfunding to raise equity investment capital. Part 3 will address some Potential Dangers inherent in the system of crowdfunding being devised. We hope you find the series educational and invite you to contact the authors with questions.
Same acronym… new innovative meaning. The Biotechnology Industry Organization… better known as BIO will soon become the Biotechnology Innovation Organization. This news release from BIO says the change is to highlight the scientific innovation the group brings.
“I’m pleased to announce that the BIO Board has approved a change to BIO’s name… from the Biotechnology Industry Organization to the Biotechnology Innovation Organization,” said BIO’s new Board Chair, Ron Cohen, CEO of Acorda Therapeutics. “Still BIO, but now with a name that better expresses the essence of what our member companies represent.”
Growing companies seeking to raise up to $50 million have a new financing option, starting Friday: a process that will open some private businesses to a wide pool of new investors.
More than three years in the making, the regulatory change, an expanded version of a rule known as Regulation A, is intended to let promising companies — the kinds typically backed by venture capitalists and wealthy angel investors — raise money by selling equity stakes to people of more modest means.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
- Applicant Responsibilities in Maintaining the Integrity of NIH Peer Review
- Deadline for Final Reports Required for Grant Closeout
- Registration Open for the 2nd NIH Regional Seminar on Program Funding & Grants Administration - San Diego, CA - October 14-16, 2015
- Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01)
- Application Receipt/Submission Date(s): October 21, 2015; June 21, 2016; October 21, 2016; June 21, 2017; October 20, 2017; and June 21, 2018, by 5:00 PM local time of applicant organization.
- Multidisciplinary Studies of HIV/AIDS and Aging (R01)
- Application Receipt/Submission Date(s): Multiple dates, see announcement.
- Multidisciplinary Studies of HIV/AIDS and Aging (R21)
- Application Receipt/Submission Date(s): Multiple dates, see announcement.
Please note that most links to RFAs, PAs, and Guide Notices will take you to the NIH Web site. RFPs will take you to FedBizOpps. Links to RFPs will not work past their proposal receipt date. Archived versions of RFPs posted on FedBizOpps can be found on the FedBizOpps site using the FedBizOpps search function. Under “Document to Search,” select Archived Documents.
Thank you for joining us at Health Datapalooza 2015! The event was a huge success, bringing together more than 1,600 consumers, providers, payors, researchers, innovators, policy makers, and many more health data thought leaders for three days of networking and learning.
This year’s event highlights included a new series of main stage panel discussions as well as the announcement of the Obesity Challenge, a groundbreaking initiative to improve health and well-being in both the U.S. and U.K.
One of the exciting and frustrating things about convergence, particularly in healthcare, is that it’s tough to predict how the hybrid technologies will find their way to market. The process of reaching that goal is filled with unexpected obstacles, twists and pivots.
Lake Whillans, in an effort to help level the playing field for entrepreneurs in the new world of healthcare investing, has partnered with MedCity News to deliver independent research on corporate venture capital in the life sciences. MedCityNews.com reached out to its 400,000 monthly readers, and more than 450 healthcare innovators familiar with corporate firms shared their insights.
Medical care today is episodic. We’re assessed by our doctors at our annual physical exams, and we’re treated by our doctors when symptoms of ill-health become manifest. In the periods in between, we’re unmoored and untended, perhaps engaging in behaviors that will sabotage our health. And because medical care today is driven by data derived from physician encounters, it becomes an explicitly physician-focused dynamic. If health care data were to be continually collected and assessed independent of physician encounters, medical care might finally be transformed to become a patient-focused dynamic instead, yielding efficiencies, improved outcomes, and lower costs.
From SBIR Gateway:
There are a number of items I want to discuss with you but tonight there is only time for a few very time sensitive items that may be of interest to you. Item #1 is the DoD SBIR submission site because Tuesday is your last full day to submit for the DoD 15.2 SBIR and 15.B STTR, (submission closes Wednesday June 24, at 6:00am edt). Item # 2 is all important patent legislation which is supposed to be voted on this week in the House (H.R. 9 "Innovation Act") and the Senate's version (S. 1137 "Protecting American Talent and Entrepreneurship" [PATENT] Act). Both of these items have the potential for causing small businesses plenty of grief.
Victor and Lynne Brick, owners of Brick Bodies Fitness Services, Inc., a chain of coed and women-only health clubs, established the John W. Brick Mental Health Foundation (501c3) to support research and education in mental health. Honoring Victor’s brother John, who suffered from schizophrenia and eventually succumbed to complications from the disease, the John W. Brick Mental Health Foundation is dedicated to advancing research towards a comprehensive scientific understanding of relationships between exercise and mental health. The John W. Brick Mental Health Foundation will support a program of studies for that purpose, and the dissemination and application of results.